Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor–Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer

Anthony Bonaventura; Rachel L. O'Connell; Cristina Mapagu; Philip J. Beale; Orla M. McNally; Linda R. Mileshkin; Peter T. Grant; Alison M. Hadley; Jeffery C.H. Goh; Katrin M. Sjoquist; Julie Martyn; Anna DeFazio; James Scurry; Michael L. Friedlander

doi:10.1097/IGC.0000000000000978

Article info

Ovarian Cancer

Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor–Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer

Authors

Anthony Bonaventura Calvary Mater Newcastle, Newcastle; PubMed articles Google scholar articles
Rachel L. O'Connell National Health and Medical Research Council Clinical Trials Centre and PubMed articles Google scholar articles
Cristina Mapagu Westmead Institute for Medical Research, University of Sydney, Sydney;Department of Gynaecological Oncology, Westmead Hospital, Westmead; andSchool of Medicine, Western Sydney University; PubMed articles Google scholar articles
Philip J. Beale Chris O’Brien Lifehouse; andSchool of Medicine, University of Sydney, Sydney, New South Wales; PubMed articles Google scholar articles
Orla M. McNally Royal Women’s Hospital;University of Melbourne; PubMed articles Google scholar articles
Linda R. Mileshkin Division of Cancer Medicine, Peter MacCallum Cancer Centre; and PubMed articles Google scholar articles
Peter T. Grant Mercy Hospital for Women, Melbourne, Victoria; PubMed articles Google scholar articles
Alison M. Hadley Royal Brisbane and Women’s Hospital andSchool of Medicine, University of Queensland, Brisbane, Queensland; and PubMed articles Google scholar articles
Jeffery C.H. Goh Royal Brisbane and Women’s Hospital andSchool of Medicine, University of Queensland, Brisbane, Queensland; and PubMed articles Google scholar articles
Katrin M. Sjoquist National Health and Medical Research Council Clinical Trials Centre and PubMed articles Google scholar articles
Julie Martyn National Health and Medical Research Council Clinical Trials Centre and PubMed articles Google scholar articles
Anna DeFazio Westmead Institute for Medical Research, University of Sydney, Sydney;Department of Gynaecological Oncology, Westmead Hospital, Westmead; and PubMed articles Google scholar articles
James Scurry Pathology North andFaculty of Health and Medicine, University of Newcastle, Newcastle; and PubMed articles Google scholar articles
Michael L. Friedlander Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia. PubMed articles Google scholar articles

Address correspondence and reprint requests to Michael L. Friedlander, AM, FRACP, Paragon Trial, NHMRC Clinical Trials Centre, Locked Bag 77, Camperdown, New South Wales 1450, Australia. E-mail: m.friedlander@unsw.edu.au.

Citation

Bonaventura A, O'Connell RL, Mapagu C, et al

Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor–Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer

International Journal of Gynecologic Cancer 2017;27:900-906.

Publication history

Received October 16, 2016
First published June 1, 2017.

Online issue publication

February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password